Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Clinical trial NCT00022048 · COMPLETED

Trial details

NCT number: NCT00022048
Sponsor: Stanford University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms

Start date: 2001-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.